Pharmaceutical Biotechnology

Pharmaceutical Biotechnology is a multidisciplinary topic that provides insight into the process of biopharmaceutical drug discovery and its impact on the practice of medicine. It focusses on the wide spread dispersal of recent developments in biotechnological tools and techniques and evolution of novel pharmaceutical drugs. Pharmaceutical biotechnological research includes studies on the application of recombinant DNA technology, microbiology, genomics, proteomics and industrial biotechnology.Pharmacogenomics is the study of the role of the genome in drug response.. Pharmacogenomics analyses how the genetic makeup of an individual affects his/her response to drugs. It deals with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with pharmacokinetics (drug absorptiondistributionmetabolism, and elimination) and pharmacodynamics (effects mediated through a drug's biological targets). The term pharmacogenomics is often used interchangeably with pharmacogenetics. Although both terms relate to drug response based on genetic influences, pharmacogenetics focuses on single drug-gene interactions, while pharmacogenomics encompasses a more genome-wide association approach, incorporating genomics and epigenetics while dealing with the effects of multiple genes on drug response.

 

  • Track 1-1 chemotherapy
  • Track 2-2 Human Genomics
  • Track 3-3 Clinical trails
  • Track 4-4 Antibodies
  • Track 5-5 Cell therapies

Related Conference of Microbiology